$CSL:ASX - CSL LIMITED - Mega whale showing signs of recovery

12 Agu 2019

CSL is one of those mega stocks everyone used to have in their portfolios which is up something like 28,000% since the mid 90's. After the recent sell off it looks like its showing signs of recovery. Might be a day or two early, but certainly worth a watch.

Currently 739 buyers for 131,397 units vs 415 sellers for 80,974 units

CSL Limited is a biotherapeutics company that develops and delivers biotherapies. The Company's principal activities are research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. Its segments include CSL Behring, Seqirus and CSL Intellectual Property. The CSL Behring segment manufactures, markets and develops plasma therapies (plasma products and recombinants). The Seqirus segment manufactures and distributes non-plasma biotherapeutic products. Seqirus manufactures, sells and distributes a range of vaccines, antivenoms and other pharmaceutical products in Australia and New Zealand. It also manufactures and markets in vitro diagnostic products through Seqirus immunohematology. The CSL Intellectual Property segment is engaged in licensing of intellectual property generated by the Company to unrelated third parties. The Company has facilities in Australia, Germany, Switzerland, the United Kingdom and the United States.

24 Sep 2019

Catatan

Slow and steady. Starting to push up near that $240 mark for a 7% gain so far.

14 Nov 2019

Catatan

Slow and steady and now at 52-week highs for a 20% gain.

10 Des 2019

Catatan

CSL touched just under $290 and a bit of a pullback. Looks like it could be at another reasonably value area for anyone looking for an entry for a good longer term stock.

5 Jan 2020

Catatan

CSL is a little bit stuck at the moment ranging sideways in a +- 5% channel. Could be at a good value area for anyone looking for an entry or to top up. Volume is a bit weak so perhaps look for confirmation of an upward move before committing.

31 Jan 2020

Catatan

Could be a good time to enter after a minor pullback. Now up roughly 70% over the last 12 months. 8% trailing sell would have kept you in the trade for the duration.

13 Feb 2020

Catatan

Safely past earnings. Pushing $330 now.